Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

MYRIAD GENETICS INC — Myriad Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / MYRIAD GENETICS INC

MYRIAD GENETICS INC

10% owner at Myriad Pharmaceuticals, Inc. · on record since Jun 19, 2009

Insider trading activity of MYRIAD GENETICS INC

Transactions on record: 1; since Jun 19, 2009

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 19, 2009

Figures computed from official regulatory filings — methodology.

Companies where MYRIAD GENETICS INC has traded

Myriad Pharmaceuticals, Inc.1 tx · Jun 19, 2009

Track record of MYRIAD GENETICS INC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of MYRIAD GENETICS INC

Co-insiders of MYRIAD GENETICS INC

Arnhold & S. Bleichroeder Advisers, LLCMyriad Pharmaceuticals, Inc.
Aryeh JasonMyriad Pharmaceuticals, Inc.
Belle Gerald P.Myriad Pharmaceuticals, Inc.
Berry BarbaraMyriad Pharmaceuticals, Inc.
BREWER RICHARD BMyriad Pharmaceuticals, Inc.
COUCHMAN JONATHANMyriad Pharmaceuticals, Inc.
Forrester RobertMyriad Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Franson Timothy RMyriad Pharmaceuticals, Inc.

Gibbs AndrewMyriad Pharmaceuticals, Inc.

GRYSKA DAVID WMyriad Pharmaceuticals, Inc.

HENDERSON JOHN TMyriad Pharmaceuticals, Inc.

HOBDEN ADRIAN NMyriad Pharmaceuticals, Inc.

Kendell AndreaMyriad Pharmaceuticals, Inc.

LANGER DENNISMyriad Pharmaceuticals, Inc.

Laslie W WayneMyriad Pharmaceuticals, Inc.

LOLLINI ROBERT JMyriad Pharmaceuticals, Inc.

Pearce Michael CooperMyriad Pharmaceuticals, Inc.

SCHEIWE STEVEN DMyriad Pharmaceuticals, Inc.

Swabb EdwardMyriad Pharmaceuticals, Inc.

Xstelos Corp.Myriad Pharmaceuticals, Inc.

Xstelos Holdings, Inc.Myriad Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Myriad Pharmaceuticals, Inc.	Jun 19, 2009	Other	-23,957,241	0.00	$0	SEC